ULTRAGENYX PHARMACEUTICAL INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $66.7M | $540.6M | $161.1M |
| FY2017 | $107.3M | $490.8M | $100.5M |
| FY2018 | $110.7M | $719.6M | $113.4M |
| FY2019 | $481.7M | $1.14B | $433.6M |
| FY2020 | $605.2M | $1.76B | $713.5M |
| FY2021 | $599.8M | $1.52B | $307.6M |
| FY2022 | $1.19B | $1.55B | $132.9M |
| FY2023 | $1.22B | $1.49B | $214.0M |
| FY2024 | $1.24B | $1.50B | $174.0M |
| FY2025 | $1.61B | $1.53B | $421.0M |